MicroRNA-130a targets MAP3K12 to modulate diabetic endothelial progenitor cell function

Cellular Physiology and Biochemistry

Volumn 36, Issue 2, 2015, Pages 712-726

  Ye, Meng ^a   Li, Dan ^a   Yang, Jian ^b   Xie, Jing ^a   Yu, Fei ^a   Ma, Yushui ^a   Zhu, Xuchao ^a   Zhao, Jinwei ^c   Lv, Zhongwei ^a,d  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c Laiyang Central Hospital   (China)

^d TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

Endothelial progenitor cell; JNK signal pathway; MAP3K12; MicroRNA 130a

Indexed keywords

CD34 ANTIGEN; GLUCOSE; JANUS KINASE; MICRORNA; MICRORNA 130A; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3 KINASE 12; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; MIRN130 MICRORNA, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 12;

APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; AGED; CELL CULTURE; CYTOLOGY; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; UPREGULATION;

AGED; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; ENDOTHELIAL PROGENITOR CELLS; FEMALE; HUMANS; MALE; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MICRORNAS; MIDDLE AGED; UP-REGULATION;

EID: 84929693062     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430132     Document Type: Article

References (36)

1. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
2. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G: Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999-1007.
3. van den Oever IA, Raterman HG, Nurmohamed MT, Simsek S: Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. Mediators Inflamm 2010;2010:792393.
4. Moreno PR, Fuster V: New aspects in the pathogenesis of diabetic atherothrombosis. J Am Coll Cardiol 2004;44:2293-2300.
5. Ho FM, Lin WW, Chen BC, Chao CM, Yang CR, Lin LY, Lai CC, Liu SH, Liau CS: High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eN0S pathway. Cell Signal 2006;18:391-399.
6. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R: Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev2006;20:515-524.
7. Meng S, Cao JT, Zhang B, Zhou Q, Shen CX, Wang CQ: Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J Mol Cell Cardiol 2012;53:64-72.
8. Meng S, Cao J, Wang L, Zhou Q, Li Y, Shen C, Zhang X, Wang C: MicroRNA 107 partly inhibits endothelial progenitor cells differentiation via HIF-lbeta. PLoS One 2012;7:e40323.
9. Zhao T, Li J, Chen AF: MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am J Physiol Endocrinol Metab 2010;299:E110-116.
10. Meng S, Cao J, ZhangX, Fan Y, Fang L, Wang C, Lv Z, Fu D, Li Y: Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3. PLoS One 2013;8:e68611.
11. Itoh A, Horiuchi M, Bannerman P, Pleasure D, Itoh T: Impaired regenerative response of primary sensory neurons in ZPK/DLK gene-trap mice. Biochem Biophys Res Commun 2009;383:258-262.
12. Weston CR, Davis RJ: The JNK signal transduction pathway. Curr Opin Genet Dev 2002;12:14-21.
13. Weston CR, Davis RJ: The JNK signal transduction pathway. Curr Opin Cell Biol 2007;19:142-149.
14. Yang R, Trevillyan JM: c-Jun N-terminal kinase pathways in diabetes. Int J Biochem Cell Biol 2008;40:2702-2706.
15. Ma FX, Zhou B, Chen Z, Ren Q, Lu SH, Sawamura T, Han ZC: Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res 2006;47:1227-1237.
16. Chen X, Gong J, Zeng H, Chen N, Huang R, Huang Y, Nie L, Xu M, Xia J, Zhao F, Meng W, Zhou Q: MicroRNA145 targets BNIP3 and suppresses prostate cancer progression. Cancer Res 2010;70:2728-2738.
17. Moebus S, Stang A, Mohlenkamp S, Dragano N, Schmermund A, Slomiany U, Hoffmann B, Bauer M, Broecker-Preuss M, Mann K, Siegrist J, Erbel R, Jockel KH, Heinz Nixdorf Recall Study G: Association of impaired fasting glucose and coronary artery calcification as a marker of subclinical atherosclerosis in a population-based cohort-results ofthe Heinz Nixdorf Recall Study. Diabetologia 2009;52:81-89.
18. Avogaro A, Fadini GR Gallo A, Pagnin E, de Kreutzenberg S: Endothelial dysfunction in type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2006;16:S39-45.
19. Qing S, Yuan S, Yun C, Hui H, Mao P, Wen F, Ding Y, Liu Q: Serum miRNA biomarkers serve as a fingerprint for proliferative diabetic retinopathy. Cell Physiol Biochem 2014;34:1733-1740.
20. Kovaleva V, Mora R, Park YJ, Plass C, Chiramel AI, Bartenschlager R, Dohner H, Stilgenbauer S, Pscherer A, Lichter P, Seiffert M: miRNA-130a targets ATG2B and D1CER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. Cancer Res 2012;72:1763-1772.
21. Wang XC, Tian LL, Wu HL, Jiang XY, Du LQ, Zhang H, Wang YY, Wu HY, Li DG, She Y, Liu QF, Fan FY, Meng AM: Expression of miRNA-130a in nonsmall cell lung cancer. Am J Med Sci 2010;340:385-388.
22. Shaulian E, Karin M: AP-1 as a regulator of cell life and death. Nat Cell Biol 2002;4:E131-136.
23. Bennett BL, Satoh Y, Lewis AJ: JNK: A new therapeutic target for diabetes. Curr Opin Pharmacol 2003;3:420-425.
24. Maundrell K, Antonsson B, Magnenat E, Camps M, Muda M, Chabert C, Gillieron C, Boschert U, Vial-Knecht E, Martinou JC, Arkinstall S: Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence ofthe constitutively active GTP-binding protein Racl. J Biol Chem 1997;272:25238-25242.
25. Yamamoto K, Ichijo H, Korsmeyer SJ: BCL-2 is phosphorylated and inactivated by an ASKl/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 1999;19:8469-8478.
26. Lei K, Davis RJ: JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci U S A 2003;100:2432-2437.
27. Putcha GV, Le S, Frank S, Besirli CG, Clark K, Chu B, Alix S, Youle RJ, LaMarche A, Maroney AC, Johnson EM Jr: JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis. Neuron 2003;38:899-914.
28. Becker EB, Howell J, Kodama Y, Barker PA, Bonni A: Characterization of the c-Jun N-terminal kinase-BimEL signaling pathway in neuronal apoptosis. J Neurosci 2004;24:8762-8770.
29. Kim BJ, Ryu SW, Song BJ: JNK-and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J Biol Chem 2006;281:21256-21265.
30. Rogakou EP, Nieves-Neira W Boon C, Pommier Y, Bonner WM: Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J Biol Chem 2000;275:9390-9395.
31. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM: A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 2000;10:886-895.
32. Liu J, Lin A: Role of JNK activation in apoptosis: A double-edged sword. Cell Res 2005;15:36-42.
33. Huntwork-Rodriguez S, Wang B, Watkins T, Ghosh AS, Pozniak CD, Bustos D, Newton K, Kirkpatrick DS, Lewcock JW: JNK-mediated phosphorylation of DLK suppresses its ubiquitination to promote neuronal apoptosis. J Cell Biol 2013;202:747-763.
34. Aguirre V, Uchida T, Yenush L, Davis R, White MF: The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 2000;275:9047-9054.
35. Lee YH, Giraud J, Davis RJ, White MF: c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem 2003;278:2896-2902.
36. Ricci R, Sumara G, Sumara I, Rozenberg I, Kurrer M, Akhmedov A, Hersberger M, Eriksson U, Eberli FR, Becher B, Boren J, Chen M, Cybulsky MI, Moore KJ, Freeman MW, Wagner EF, Matter CM, Luscher TF: Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science 2004;306:1558-1561.